Fanny Beaupel-Charbonnier
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Three to four mRNA COVID-19 vaccines in multiple sclerosis patients on immunosuppressive drugs: Seroconversion and variant neutralization.
Journal: European journal of neurology
Published: February 13, 2023
Suggestive association between OPRM1 and impulse control disorders in Parkinson's disease.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: January 13, 2018
Molecular basis of dopamine replacement therapy and its side effects in Parkinson's disease.
Journal: Cell and tissue research
Published: September 20, 2017
A randomized, controlled, double-blind, crossover trial of triheptanoin in alternating hemiplegia of childhood.
Journal: Orphanet journal of rare diseases
Published: April 06, 2017
Bee Venom for the Treatment of Parkinson Disease - A Randomized Controlled Clinical Trial.
Journal: PloS one
Published: November 24, 2015
A randomized, controlled, double-blind, crossover trial of zonisamide in myoclonus-dystonia.
Journal: Neurology
Published: July 29, 2015
Gene expression analyses identify Narp contribution in the development of L-DOPA-induced dyskinesia.
Gene expression analyses identify Narp contribution in the development of L-DOPA-induced dyskinesia.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience
Published: January 09, 2015
Mitogen- and stress-activated protein kinase 1 is required for specific signaling responses in dopamine-denervated mouse striatum, but is not necessary for L-DOPA-induced dyskinesia.
Journal: Neuroscience letters
Published: July 02, 2014
Dopa-decarboxylase gene polymorphisms affect the motor response to L-dopa in Parkinson's disease.
Journal: Parkinsonism & related disorders
Published: July 31, 2013
Last Updated: 09/26/2026